What is acetyl-L-carnitine? A plain-English guide
Acetyl-L-carnitine is a form of carnitine, found in food and made by the body. It has been studied mostly in older adults and people with a health condition. A large 1-year trial in Alzheimer's disease found it did not slow decline. In one trial in women having chemotherapy, it increased nerve symptoms compared with a placebo.
By the NootropicsWork Editorial Team. A plain-English guide, 5 minute read.
Bottom line
Acetyl-L-carnitine is a form of carnitine, found in food and made by the body. It has been studied mostly in older adults and people with a health condition. A large 1-year trial in Alzheimer's disease found it did not slow decline. In one trial in women having chemotherapy, it increased nerve symptoms compared with a placebo.
- In a 2003 Cochrane review of 11 trials in people with a diagnosed memory condition, acetyl-L-carnitine showed no benefit on tests of thinking [1].
- A trial in adults over 70 with long-lasting tiredness reported lower mental-fatigue scores than a comparison group [4]. But a Cochrane review of five liver-disease trials found no clear difference in fatigue and rated the evidence very low quality [5].
- In a 24-week trial in 409 women having chemotherapy for breast cancer, acetyl-L-carnitine increased nerve symptoms compared with a placebo [7].
For every study, dose and grade, read our full research summary on Acetyl-L-carnitine.
What is acetyl-L-carnitine?
Carnitine is a name for several related compounds, including acetyl-L-carnitine [10]. Studies often shorten its name to ALCAR [2][3]. It and plain L-carnitine are the two main forms sold as supplements [10].
Carnitine is found in many foods, especially foods from animals [10]. The liver, kidneys and brain also make it [10].
Reviewers think it may act on nerve cells that use the brain chemical acetylcholine [1]. It may also act on mitochondria, the parts of cells that make energy [1]. These ideas do not show that it changes anything in people.
What do people use acetyl-L-carnitine for?
Researchers have studied it for memory and thinking in people with Alzheimer's disease or milder memory problems [1][2]. They have studied it for tiredness in older adults [4]. And they have studied it for low mood, mostly in people with a diagnosed mood condition [6].
Healthy adults are mostly missing from this research. We searched PubMed on November 11, 2026, and Europe PMC for thinking studies. As of that date we found no randomized placebo-controlled trials of it in healthy adults on thinking, mood or fatigue.
What does the research show?
A placebo is a dummy pill with nothing active in it. A meta-analysis pools the results of several trials.
Does acetyl-L-carnitine help memory and thinking?
Evidence grade for global cognition: C, limited. Why this grade
Evidence is mixed, and the trials here were all in people with memory problems or Alzheimer's disease [1][2]. Results may not apply to healthy adults.
A 2003 meta-analysis looked at trials in people with mild cognitive impairment (memory and thinking problems milder than dementia) or mild Alzheimer's disease [2]. Compared with a placebo, acetyl-L-carnitine showed a small advantage on a combined score of several tests [2].
The 2003 Cochrane review included 11 trials, all in people with Alzheimer's disease [1]. It found no benefit on thinking, how severe the dementia was, or daily tasks [1]. It did find a benefit on one overall rating made by clinicians. But the reviewers said this may be due to chance [1].
In a 1-year trial, 431 people aged 50 or older with mild to moderate Alzheimer's disease were randomly given acetyl-L-carnitine or a placebo [3]. Neither they nor the researchers knew who got which [3]. Both groups declined at the same rate on the main measures [3].
Does acetyl-L-carnitine help with mental tiredness?
Evidence grade for mental fatigue: C, limited. Why this grade
The evidence is small and comes from older or ill groups, so results may not apply to healthy adults [4][5].
In a trial of 96 adults over 70 who had long-lasting tiredness, mental-fatigue scores fell by 3.3 points with acetyl-L-carnitine [4]. In the comparison group, scores rose by 0.6 points [4]. The short summary of that study does not say what the comparison group got [4].
A 2019 Cochrane review looked at five trials, with 398 people in all [5]. All were run by one team in Italy, in adults with advanced liver disease that was affecting the brain [5]. It found no clear difference in fatigue between acetyl-L-carnitine and a placebo [5]. It rated that evidence very low quality [5].
Does acetyl-L-carnitine affect mood?
Evidence grade for mood: C, limited. Why this grade
The mood studies were mostly in people with a diagnosed condition such as depression [6]. Results may not apply to healthy adults.
A 2018 meta-analysis included 12 trials with 791 people [6]. Pooling nine of those trials, people on acetyl-L-carnitine had fewer depressive symptoms than people on a placebo or no treatment [6]. But the trials disagreed a lot about how big that effect was [6]. The authors said large trials are needed to check the findings [6].
To see what each grade means, read how we grade evidence.
How much did studies use?
Table: Doses used in studies (not a recommendation)
| What was studied | Doses used in studies | Source |
|---|---|---|
| Memory problems and mild Alzheimer's disease (meta-analysis) | 1.5-3.0 g a day for 3, 6 or 12 months | [2] |
| Alzheimer's disease (1-year trial) | 3 g a day, as 1 g three times a day, for 12 months | [3] |
| Women having chemotherapy (safety trial) | 3,000 mg a day for 24 weeks | [7] |
These are amounts used in research, not advice. Health Canada's rules say products combining L-carnitine with acetyl-L-carnitine cannot go over 4 grams a day or 2 grams per dose [9].
Is acetyl-L-carnitine safe?
In trials in Alzheimer's disease, it was reported as well tolerated [2][3]. The Cochrane dementia review found no clear difference in side effects between it and a placebo [1].
The 2019 liver-disease review said side effects were poorly reported, so harms remain unclear [5].
The NIH Office of Dietary Supplements says carnitine has no official upper limit for daily intake [10]. It says about 3 g a day can cause nausea, vomiting, stomach cramps, diarrhea and a fishy body odor [10]. As of November 11, 2026, our PubMed and Europe PMC searches found no systematic review of its safety.
A warning sign comes from a publicly funded trial in women having taxanes, a type of chemotherapy, for breast cancer [7]. In this 24-week trial, 409 women were randomly given 3,000 mg a day or a placebo [7]. Neither they nor the researchers knew who got which [7]. At 12 weeks, the trial found no clear effect on nerve symptoms [7]. But by 24 weeks, acetyl-L-carnitine had increased nerve symptoms caused by the chemotherapy [7]. Severe nerve problems were also more common with it, with eight cases compared with one [7].
A two-year follow-up of the same women found nerve symptoms were worse overall with acetyl-L-carnitine [8].
Talk to a clinician or pharmacist before trying it, especially during cancer treatment.
Who should be careful with acetyl-L-carnitine?
Health Canada's rules for L-carnitine products require a label warning [9]. It advises asking a health professional before use during pregnancy or breastfeeding, or for people with a seizure disorder [9]. The rules do not say whether these cautions were checked for acetyl-L-carnitine alone [9]. The NIH fact sheet adds that carnitine can cause seizures in such people [10].
In people having taxane chemotherapy, acetyl-L-carnitine increased nerve symptoms [7][8].
Seizure medicines, such as valproic acid, phenobarbital, phenytoin and carbamazepine, lower blood carnitine levels, the NIH fact sheet says [10]. As of November 11, 2026, our PubMed search found no study designed to test its interactions with medicines. If you take any of these medicines, talk to your doctor or pharmacist before combining them with acetyl-L-carnitine.
Want the full picture?
Every study, effect with medicines and rule by country is in Acetyl-L-carnitine: full research summary.
Grades for the outcomes on this page, from the Acetyl-L-carnitine research summary. They update when the evidence does.
| Outcome | Grade | Basis | Modifiers | Rationale |
|---|---|---|---|---|
| Global cognition | , No effect foundEvidence maturity: Established | Results only in clinical/older populations (mild cognitive impairment, Alzheimer's disease) being extrapolated to healthy adults | Why C grade for Global cognition: explainedApproved of the Global cognition grade | |
| Mental fatigue | , No effect foundEvidence maturity: Emerging | Small RCTs only in clinical/older populations (adults over 70 with fatigue; hepatic encephalopathy) extrapolated to healthy adults | Single research groupSubjective outcome only | Why C grade for Mental fatigue: explainedApproved of the Mental fatigue grade |
| Mood | , Benefit foundEvidence maturity: Emerging | Meta-analyses exist but only in clinical populations (mostly diagnosed depressive and dysthymic disorders), extrapolated to healthy adults; pooled placebo comparison highly heterogeneous | Why C grade for Mood: explainedApproved of the Mood grade |
Qualia Mind 2.0 contains Acetyl-L-carnitine
Acetyl-L-carnitine is one of 31 ingredient entries on the Qualia Mind 2.0 label. The grades on this page are for Acetyl-L-carnitine on its own, not for the product.
Our Qualia Mind 2.0 review compares each label dose with the doses used in studies.
We earn a commission if you buy through this link. It never changes a grade or a verdict. How we make money.
References
- Hudson S, Tabet N. Acetyl-L-carnitine for dementia. Cochrane Database Syst Rev. 2003.
- Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol. 2003.
- Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 1996.
- Malaguarnera M, Gargante MP, Cristaldi E, et al. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Arch Gerontol Geriatr. 2008.
- Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, et al. Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database Syst Rev. 2019.
- Veronese N, Stubbs B, Solmi M, et al. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosom Med. 2018.
- Hershman DL, Unger JM, Crew KD, et al. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. J Clin Oncol. 2013.
- Hershman DL, Unger JM, Crew KD, et al. Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). J Natl Cancer Inst. 2018.
- Health Canada (Natural and Non-prescription Health Products Directorate). Natural Health Products Ingredients Database monograph: L-Carnitine. Updated July 25, 2025.
- NIH Office of Dietary Supplements. Carnitine: Fact Sheet for Health Professionals (as archived). Updated April 17, 2023.